Omega-3 fatty acids in heart disease—why accurately measured levels matter

Current guidelines barely support marine omega‑3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in cardiology, mainly because results of large trials were equivocal. Most large trials have tested EPA alone or EPA + DHA combined as a drug, thereby disregarding the relevance of...

Descripción completa

Detalles Bibliográficos
Autores principales: von Schacky, C., Kuipers, R. S., Pijl, H., Muskiet, F. A. J., Grobbee, D. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602979/
https://www.ncbi.nlm.nih.gov/pubmed/36795219
http://dx.doi.org/10.1007/s12471-023-01759-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602979/
https://www.ncbi.nlm.nih.gov/pubmed/36795219
http://dx.doi.org/10.1007/s12471-023-01759-2

Ejemplares similares